| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H22O4 |
| Molecular Weight | 314.3756 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)[C@@H]1CC2=CC3=C(OC(=O)C(=C3)C(C)(C)C=C)C=C2O1
InChI
InChIKey=JCDLLLXYAICSQV-INIZCTEOSA-N
InChI=1S/C19H22O4/c1-6-18(2,3)13-8-11-7-12-9-16(19(4,5)21)22-14(12)10-15(11)23-17(13)20/h6-8,10,16,21H,1,9H2,2-5H3/t16-/m0/s1
| Molecular Formula | C19H22O4 |
| Molecular Weight | 314.3756 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 64.0 µM [IC50] | |||
| 27.64 µM [IC50] | |||